Brain Metastasis Velocity (BMV) Model
Brain Metastasis Velocity estimates the aggressiveness of intracranial disease by measuring the rate at which new brain metastases develop over time.
Indicazioni d'uso
Used to quantify rate of new brain metastases over time to identify patients at high risk for rapid intracranial progression. Helps guide:
- Escalation to WBRT or systemic therapy when BMV is high (greater progression risk noted in ASCO-SNO-ASTRO discussion 1 [Level III evidence]).
- SRS alone with close MRI surveillance when BMV is low and prognosis favorable.
- Prognostic counseling alongside DS‑GPA and tumor volume models.
Approfondimenti e precauzioni
Predict faster intracranial failure when lesion accrual exceeds ~4 new metastases per year, indicating aggressive biology and poorer survival (ASCO‑SNO‑ASTRO guideline: no validated thresholds; use cautiously) 1 [Level I evidence].
- Prognostic value is not formally validated across histologies and is not incorporated in DS‑GPA updates (large cohorts 6,984 and 1,796 patients) 2 [Level I evidence]; 3 [Level II evidence].
- Do not use as a sole determinant of SRS vs WBRT; guidelines advise insufficient evidence for treatment decisions.